Georgia joins a $26 billion US opioid settlement in a U.S. reversal
Georgia has opted to join a proposed $26 billion nationwide settlement settling claims alleging that three giant drug distributors and drugmaker Johnson & Johnson (NYSE:)…
Georgia has opted to join a proposed $26 billion nationwide settlement settling claims alleging that three giant drug distributors and drugmaker Johnson & Johnson (NYSE:)…